Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Andersen

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Pharmatherapeutica|January 1, 1989
Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre studyE Fuglum, A Schillinger, J B Andersen, et al.
Allergy|May 1, 1986
Nebulised sodium cromoglycate in the treatment of wheezy bronchitis. A multicentre double-blind placebo controlled studyA Bertelsen, J B Andersen, P Busch, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 17, 2016
Optimum bolus wizard settings in insulin pumps in children with Type 1 diabetesA J B Andersen, A Ostenfeld, C B Pipper, et al.
Oncogene|November 30, 2006
Role of 2-5A-dependent RNase-L in senescence and longevityJ B Andersen, X L Li, C S Judge, et al.
Ugeskrift for Laeger|October 15, 1990
[Prevention of allergy. Guiding norms]O Osterballe, J B Andersen, L Hansen, et al.
Intensive Care Medicine|January 1, 1988
ARDS after accidental inhalation of zinc chloride smokeE Hjortsø, J Qvist, M I Bud, et al.
Oncogene|April 19, 2011
Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic responseY-H Lee, A D Judge, D Seo, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 17, 2017
Differential effects of FXR or TGR5 activation in cholangiocarcinoma progressionO Erice, I Labiano, A Arbelaiz, et al.
Oncogene|July 25, 2012
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomasP Wang, Q Dong, C Zhang, et al.
BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Pharmatherapeutica|January 1, 1989
Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre studyE Fuglum, A Schillinger, J B Andersen, et al.
Allergy|May 1, 1986
Nebulised sodium cromoglycate in the treatment of wheezy bronchitis. A multicentre double-blind placebo controlled studyA Bertelsen, J B Andersen, P Busch, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 17, 2016
Optimum bolus wizard settings in insulin pumps in children with Type 1 diabetesA J B Andersen, A Ostenfeld, C B Pipper, et al.
Oncogene|November 30, 2006
Role of 2-5A-dependent RNase-L in senescence and longevityJ B Andersen, X L Li, C S Judge, et al.
Ugeskrift for Laeger|October 15, 1990
[Prevention of allergy. Guiding norms]O Osterballe, J B Andersen, L Hansen, et al.
Intensive Care Medicine|January 1, 1988
ARDS after accidental inhalation of zinc chloride smokeE Hjortsø, J Qvist, M I Bud, et al.
Oncogene|April 19, 2011
Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic responseY-H Lee, A D Judge, D Seo, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 17, 2017
Differential effects of FXR or TGR5 activation in cholangiocarcinoma progressionO Erice, I Labiano, A Arbelaiz, et al.
Oncogene|July 25, 2012
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomasP Wang, Q Dong, C Zhang, et al.
BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.
Pageof 14